title: Bevacizumab for acute branch retinal vein occlusion with subretinal hemorrhage.
authors: Department of Ophthalmology, Peking University Third Hospital; Peking University Eye Center; Key Laboratory of Vision Loss and Restoration, Ministry of Education , Beijing , P.R. China.
authors: Bingzhen
authors: B
authors: Li
authors: Kang
authors: K
authors: Feng
authors: Liang
authors: L
authors: Han
authors: Zhizhong
authors: Z
authors: Ma
authors: Yuling
authors: Y
authors: Liu
authors: Lin
authors: L
authors: Zhao
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000068258:Bevacizumab / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008269:Macular Edema / Q000188:drug therapy*; D008297:Male; D012166:Retinal Hemorrhage / Q000188:drug therapy*; D012170:Retinal Vein Occlusion / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D000068258:Bevacizumab